CRcferences »

References

Adamson GM, Billings RE. Tumor necrosis factor induced oxidative stress in isolated mouse

hepatocytes. Arch Biochem Biophys 1992;294:223-229.

Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon

YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology

2000;31: 1371-1373.

Alison MR, SarrafCE. Liver cell death:patterns and mechanisms. Gut 1994;35:577-581.

Alter HJ, Purcell RH, Gerin JL, London WT, Kaplan PM, McAuliffe VJ, Wagner J, Holland

PV. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen- positive saliva

and semen. Infect Immun 1977;16:928-933.

Alter MJ. Epidemiology and prevention of hepatitis B. Seminars in Liver Diseases

2003;23:39-46.

Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang S, Chisari

FV. MechaniSms of class I restricted immunopathology. A transgenic mouse model of

fulminant hepatitis. J Exp Med 1993;178:1541-1554.

Ando K, Guidotti LG, Wirth S, Ishikawa T, MiSsale G, Moriyama T, Schreiber RD, Schlicht

H J, Chisari FV. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their

target cells. J Immunol 1994; 152:3245-3253.

Andus T, bauer J, Gerok W. Effects ofcytokines on the liver. Heaptology 1991;13:364-375.

Awad MR, EI-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic

variation in the transfonning growth factor-betal gene: associationwith transfonning growth

factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation.

Transplantation 1998;66: 1014-1020.

Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of

linker-scan mutants spanning the -376, -488, -244, and -418 polymorphic sites of the TNF­

alpha promoter. Cytokine 2001;14:316-323.

92

References

Bellamy R, Ruwende C, Corrah T, McAdam KP, Thursz M, Whittle HC, Hill AV.

Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D

receptor gene. J Infect Dis 1999; 179:721-724.

Ben-Ari Z, Mor E, Papo 0, Kfir B, Sutkes J, Tambur AR, Tur-Kaspa R, Klein T. Cytokine

gene polymorph isms in patients infected with hepatitis B virus. Am J Gastroenterol

2003;98:144-150.

Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, Guilhot

S, Chisari FV. HLA class I-restricted human cytotoxic T cells recognize endogenously

synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 1991;88:10445-

10449.

Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T

lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 2000; 12:403-408.

Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDennott MF, Oksenberg J,

McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human

disease: on-line databases. Genes Immunity 1999;1:3-19.

Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH.

Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatol

2003;38:674-682.

Blumberg BS, Gerstley BSJ, Hungerford DA, London WT, Sutnick AJ. A Serum Antigen

(Australia Antigen) in Down's Syndrome, Leukemia and Hepatitis. Annals of Internal

Medicine 1967;66:924-931.

Blumberg BS, Friedlaender JS, Woodside A, Sutnick AI, London WT. Hepatitis and

Australian antigen autosomal recessive inheritance of susceptibility to infection in humans.

Proc. Natl. Acad. Sci. USA 1969;62, 1108-1115.

BOOr U, Fennekohl A, Pilschel GP. Sensitization by interleukin-6 of rat hepatocytes to tumor

necrosis factor a-induced apoptosis. J Hepatol 2003;38:728-735.

93

References

Bour ES, Ward LK, Cornman GA, Isom HC. Tumor necrosis factor-alpha-induced apoptosis

in hepatocytes in long-term culture. Am J Patholl996;148:485-495.

Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic

toxicity:I. TNF-induced liver injury. Am. J. PhysioI1998;275:G387-G392.

Briggs MS, Gierasch LM. Molecular mechanisms of protein secretion:The role of the signal

sequence. Advanced Protein Chemistry 1986;38:109-180.

Cain K, Freathy C. Liver toxicity and apoptosis: role of TGF-betal, cytochrome c and the

apoptosome. Toxicol Lett 2001;120:307-315.

Cambien F, Richard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G,

Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor- Bl gene in

relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-887.

Cardier JE, Erickson-Miller CL. Fas (CD95)- and tumor necrosis factor-mediated apoptosis in

liver endothelial cells: role of caspase-3 and the p38 MAPK. Microvasc Res 2002;63: 1 0-18.

Caselman WH, Meyer M, Scholz S, Hofschneider PH, Koshy R. Type I interferons inhibit

hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.

J infect Dis 1992;166:966-971

Chen R-H, Chang M-C, Su Y -H, Tsai Y -T, Kuo M-L. lnterleukin-6 inhibits transforming

growth factor-f3-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal

trallsducers and activators of transcription 3 pathways. J BioI Chern 1999;274:23013-23019.

Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to

an immunosuppressive milieu. Immunity 2001;14:715-725.

Chisari FV, Ferrari C. Hepatitis B virus immunogenesis. Annu Rev Immunoll995;13:29-60.

Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-1477.

94

References

Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology

2002;52: 113-116.

Cole SM, Gowans EJ, Macnaughton TB, Hall PD, Burell CJ. Direct evidence for cytotoxicity

associated with expression of hepatitis delta virus antigens. Hepatology.I991; 13:845-851.

Comstock GW. Tuberculosis in twins:a reanalysis of the prophit survey. Am Rev Respir Dis

1978; 117:621-624.

Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver

failure and defective hepatocyte regeneration in interleukin-6 deficient mice. Science

1996;274: 1379-1383.

D' Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the

TNF A promoter region. Immunogenetics 1994;39: 150-155.

Dane DS, Cameron CH, Briggs M. Virus-like Particles in serum of Patients with Australia­

Antigen-Associated Hepatitis. Lancet 1970; 1 :695-698.

Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus

infectious human disease. Annu Rev Genomics Hum Genet 2002;3:263-292.

De Vries RR, fat RF, Nijenhuis LE, van Rood JJ. HLA-linked genetic control of host response

to Mycobacterium leprae. Lancet 1976;2:1328-1330.

Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, Zhang R, Yao Z, Shen Y, Qiang B, Wang Y, He

F. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic

hepatitis B virus infection. Hepatology 2004;40:284-286.

Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine:multiple HLA

genes are involved. Tissue Antigens 1998;51 :593-604.

95

References

Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J,

Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. A comprehensive genetic

map of the human genome based on 5,264 microsatellites 1996;380:152-154.

Diehl AM, Rai RM. Liver regeneration 3:Regulation of signal transduction during liver

regeneration. F ASEB J 1996; 10:215-227.

Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174: 160-171.

Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, GrunerN, Zachoval R, Hoffmann

RM, Schirren CA, Scholz S, Pape GR. A vigorous virus-specific CD4+ T cell response may

contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp

ImmunoI1998;113:244-251.

Dieter P, Ambs P, Fitzke E, Schwende H. Lipopolysaccharide and liposome-encapsulated

MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor- (l and nitric

oxide in liver macrophages. Adv Exp Med BioI 1997;407:485-490.

Dieter P, Hempel U, Kamionka S, Kolada A, Malessa B, Fitzke E, Tran-Thi TA.

Prostaglandin E2 affects differently the release of inflammatory mediators from resident

macrophages by LPS and muramyl tripeptides. Mediators Inflamm 1999;8:295-303.

Doganci T, Uysal G, Kir T, Bakirtas A, Kuyucu N, Doganci L. Horizontal transmission of

hepatitis B virus in children with chronic hepatitis B. World J GastroenteroI2005;11:418-420.

Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben

Ehrmann J Jr, Galuszkova D, Ehrmann J, Krc I, Jezdinska V, Vojtesek B, Murray PG, Kolao

Z. Apoptosis-related proteins, BCL-2, BAX, F AS, F AS-L and PCNA in liver biopsies of

patients with chronic hepatitis B virus infection. Pathol Oncol Res 2000;6: 130-135.

Fang JW, Shen WW, Meager A, Lau JV. Activation of the tumor necrosis factor-a system in

the liver in chronic hepatitis B virus infection. Am J Gastroenterol 1996;91:748-753.

96

References

Fausto N, Laird AD, Webber EM. Liver regeneration 2. Role of growth factors and cytokines

in hepatic regeneration. FASEB J 1995;9:1527-1536.

Fausto N. Liver regeneration. J HepatoI2000;32:19-31.

Fine PE. Immunogentics of susceptibility to leprosy, tuberculosis and leishmaniasis. An

epidemiological perspective. Int. j. leprosy and other Mycobacterial dis 1981;49:437-454.

Fishman D, Faulds G, Jeffery R, Mohamed Ali V, Yudkin JS, Humphries S, Woo P. The

effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and

plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin.

Invest 1998; 102: 1369-1376.

Franco MA, Tin C, Rott LS. Evidence or CD8+ T-cell immunity to murine rotavirus in the

absence ofperforin, fas, and gamma interferon. J Virol 1997;71:479-486

Fulop AK, Pocsik E, Brozik M, Karabelyos C, Kiss A, Novak I, Szalai C, Dobozy 0, Falus A.

Hepatic regeneration induces transient acute phase reaction:systemic elevation of acute phase

reactants and soluble cytokine receptors. Cell BioI Int 2001;25:585-592.

Galle PRo Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel

L. Involvement of the CD95 (APO-IlFas) receptor and ligand in liver damage. J Exp Med

1995; 182: 1223-1230.

Galley HF, Lowe PRo Carmichael RL, Webster NR. Genotype and interleukin-lO responses

after cardiopulmonary bypass. Br J Anaesth 2003;91 :424-426.

Galun E, Nahor 0, Eid A, Jurim 0, Rose-John S, Blum HE, Nussbaum 0, lIan E, Daudi N,

Shouval D, Reisner Y, Dagan S. Human interleukin-6 facilitates hepatitis B virus infection in

vitro and in vivo. Virology 2000;270:299-309.

Ganem D, Schneider R. Hepadnaviridae:the viruses and their replication. In:Knipe DM,

Howley PM eds. FieldsVirology. Philadelphia:Lippincott-Raven;2001:2923-2970.

97

References

Gartner LP, Hiatt JL. Color Textbook of Histology. Philadelphia: W.B. Saunders Company,

1997.

Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Kapadia S, Trecki J, Skoner DP. Cytokine

gene polymorphisms moderate illness severity in infants with respiratory syncytial virus

infection. Hum Immunol 2003;64:338-344.

Giani G, Chiaramonte MN, Pasini CV, Fagiolo U, Naccarato R. Hepatitis B surface

antigenaemia and HLA antigens. N Engl J Med 1979;300:1056-1060.

Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV. HBsAg retention sensitizes

the hepatocyte to injury by physiological concentrations of interferon-gamma. Hepatology

1992; 16:655-663.

Gimson AE, White YS, Eddleston AL, Williams R. Clinical and Prognostic Differences in

Fulminant Hepatitis Type A, B, and non-A, non-B. Gut.1983;24:1194-1198.

Gitlin N. HepatitisB: diagnosis, prevention, and treatment. Clin Chern 1997;43:1500-1506.

Griffiths PD.lnteractions between viral and human genes. Rev Med VIf012002;12:197-199.

Grob P, Hallauer, Kane M, Meheus MA, Roure C, Damme PV. Hepatitis B: a serious public

health threat. Vaccine 1998;16:S1-S2.

Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV.

Cytotoxic T Iymhocytes inhibit hepatitis B virus gene expression by a noncytolytic

mechanism in transgenic mice. Proc Natl Acad USA 1994a;91:3764-3768.

Guidotti LG, Martinez V, Loh YT, Rogier CE, Chisari FV. Hepatitis B virus nucleocapsid

particles don't cross the hepatocyte nuclear membrane in transgenic mice. J Virol 1994

b;60:5469-5475.

Guidotti, L.G, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in

transgenic mice. J Virol 1995;69:6158-6169.

98

References

Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Shreiber R and Chisari FV. Intracellular

inactivation of the hepatitis B virus by cytotoxic T lymphocyets. Immunity 1996;4:25-36.

Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without

destruction of infected cells during acute HBV infection. Science 1999a;284:825-829.

Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV:Noncytopathic clearance

of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 1999b:189:1555-

1564 ..

Guidotti LG. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus

infection. Vaccine 2002;20:80-82.

Guilhot S, Miller T, Cornman G, [som HC. Apoptosis induced by tumor necrosis factor-a. In

rat hepatocyte cell lines expressing HBV. Am. J. Pathol 1996;148:801-814.

Guo J, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Inmaculada Barrasa M, Mason W,

Seeger C. Apoptosis and regeneration of hepatocytes during recovery from transient

hepadnavirus infections. J ViroI2000, 74:1495-1505.

Gupta V, Arora R, Ranjan A, Bairwa NK, Malhotra DK, Udhayasuriyan PT, Saba A, Bamezai

R. Gel-based nonradioactive single-strand confonnational polymorphism and mutation

detection: limitations and solutions. Methods Mol Bioi 2005;29:247-261.

Gupta V, Arora R, Saba A, Dhir A, Kar P, Bamezai R. Novel variations in the signal peptide

region of transfonning growth factor PI gene in patients with hepatitis: a brief report from

India. Internat J Immunogenet (In press).

Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen- negative chronic hepatitis

B. Hepatology 2001;34:617-624.

Hakozaki Y, Yoshiba M, Sekiyama K, Seike E, Iwamoto J, Mitani K, Mine M, Morizane T,

Ohtani K, Suzuki Y, Wakamiya N. Mannose-binding lectin and the prognosis of fulminant

hepatic failure caused by HBV infection. Liver 2002;22:29-34.

99

References

Hayashi H, Kohno H, Ono T, Yamanoi A, Dhar DK, Ueda S, Rahman MA, Kubota H,

Nagasue N. Transforming growth factor-betal induced hepatocyte apoptosis--a possible

mechanism for growth of oolorectalliver metastasis. Acta Onool 2004; 43:91-97.

Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J. Gastroentrology and

Hepatol 1997; 12 (Suppl.):S223-226.

Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, Blessing M, Schmitt E,

Lohse A W. MHC class II-expressing hepatocytes function as antigen-presenting cells and

activate specific CD4 T lymphocyutes. Hepatology 2003;37:1079-1085.

Hill A V. The immunogenetics of human infectious diseases. Annu Rev Immunol

1998;16:593-617.

Hoffinann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan OM, Kirk AD, Blair

Pl. Ethnicity greatly influences cytokine gene polymorphism distribution. Am I Transplant

2002;2:560-567.

Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, Lohr HF, Schneider PM,

Meyer zum Buschenfelde KH, Rittner C. HLA-DRB1*1301 and *1302 protect against

chronic hepatitis B. J Hepatol 1997;26:503-507.

Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, Rittner C. A

tumor necrosis factor- alpha (TNF-alpha) promoter polymorphism is associated with chronic

hepatitis B infection. Clin Exp Immunol 1998 a; III :579-582.

Hohler T, Wunschel M, Gerken G, Schneider PM, Meyer zum Buschenfelde KH' Rittner C.

No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis

B Virus infection in german patients. Exp Clin Immunogenet 1998 b;I5:130-133.

Hollinger FB, Liang TI. Hepatitis B Virus. In:Knipe OM et aI, eds. Fields Virology, 4th ed.

Philadelphia, Lippincott Williams & Wilkins, 2001:2971-3036.

100

References

Hongyo T, Buzard OS, Calvert RJ, Weghorst CM. Cold SSCP: a simple, rapid and non­

radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic

Acids Research 1993;21:3637-3642.

Howard CR. The structure of hepatitis envelope and molecular variants of hepatitis B virus. J

Viral Hepat 1995;2:165-170.

Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in

the promoter region of the huamn Apo-l/Fas (CD95) gene. Molecular Immunol 1997;34:577-

582.

Hue KK., Bechhofer DH. Effect of ermc leader region mutations on induced mRNA stability.

Journal of Bacteriology 1991;173:3732-3740.

Hue, KK and Bechhofer, DH. Effect of ermc leader region mutations on induced mRNA

stability. J. BacterioI2001;173:3732.

Ibuki N, Yamamoto K, Yabushita K, Okano N, Okamoto R, Shimada N, Hakoda T, Mizuno

M, Higashi T, Tsuji T. In situ expression ofOranzyme B and Fas-ligand in the liver of viral

hepatitis. Liver 2002;22:198-204.

Iimut'o Yr Gallucci R.Mr Lugfet' MIr {(ono Hr Thurman R.G_ Antibodie!: to tumor necrosis

iamor aiia anmmat@ h@pati(! m~(!rm!i§ ami inflammation Eaum1 h~ Ehmnk t;l:po~urn to tedum{\~

in the mt_ HepatoI1997;26:lj30-Ij37_

Iwai M, Cui TX, Kitamura H, Saito M, Shimazu T. Increased secretion of tumour necrosis

factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy.

Cytokine 200 1; 13 :60--64.

lafarzadeh A, Shokri F. The antibody response to HBs antigen is regulated by coordinated

Thl and Th2 cytokine production in healthy neonates. Clin Exp lmmunoI2003;131:451-456.

101

References

Janssen HL, Higuchi H, Abdulkarim A, Gores GJ. Hepatitis B virus enhances tumor necrosis

factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-RlIdeath

receptor 4 expression. J HepatoI2003;39:414-420.

Jiang R, Feng X, Guo Y, Lu Q, Hou J, Luo K, Fu N. T helper cells in patients with chronic

hepatitis B virus infection. Chin Med J (Engl) 2002;115:422-424.

Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and

susceptibility or resistance to chronicllepatitis B. World J GastroenteroI2003;9:2221-2225.

Jung YJ, Kim N, Park JH. TGF-betal inhibits Fas-mediated apoptosis by regulating surface

Fas and cFLIPL expression in human leukaemia/lymphoma cells. Int J Mol Med 2004; 13:99-

104.

Kagi D, Ledermann B, Burki H, Hengartener H, Zinkemagel R. CD8+ T-Cell mediated

protection against an intracellular bacterium by perforin dependent cytotoxicity. Eur J

Immunol 1994; 24:3068-3072.

Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits

hepatitis B virus replication in vivo. J Exp Med 2000; 192:921-930

Kakimi K, Lane TE, Chisari FV, Guidotti LG. Cutting Edge:lnhibition of Hepatitis B Virus

Replication by Activated NK T Cells Does Not Require Inflammatory Cell Recruitment to the

Liver. J ImmunoI.2ool;167:6701-6705.

Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Waita T, Ito Y, takayanagi M, Ida N.

Serum interleukin levels in patients with chronic hepatitis B. Am J Gastroenterol

1991 ;86: 1804-1808.

Kakumu S, Ito Y. Takayanagi M, Yoshioka K. Wakita T, Ishikawa T, Higashi Y, Yanag ZQ.

Effect of recombinant human transfonning growth factor betal on immune responses in

patients with chronic hepatitis B. Liver 1993; 13 :62-68.

102

References

Kallen K-J. The role of transsignalling via the agonistic soluble IL-6 receptor in human

diseases. BBA 2002;1592:323-343.

Kann M, Bischof A, Gerlich WHo In vitro model for the nuclear transport of the hepadnavirus

genome. J. Virol 1997;71:1310-1316.

Kann M, Gerlich W. Hepadnaviridae:structure and molecular virology. In:Zuckerman A,

Thomas H, eds. Viral Hepatitis London:Churchill Livingstone 1998;77-105.

Kaplan PM, Greenman RL, Gerin JL,Purcell RH, Robinson WS. DNA Polymerase

Associated with Human Hepatitis B Antigen. Journal or Virology 1973;12:995-1005.

Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, Seito S, Thomas HC.

Fulminant Hepatitis associated with hepatitis B virus e antigen-negative infection:importance

of host factors. Hepatology 1995;22:1628-1634.

Kardar GA, leddi-Tehrani M, Shokri F. Diminished Thl and Th2 cytokine production in

healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol

2002;55:311-314.

Kasahara S, Ando K, Saito K, Sekikawa K, Ito H, Ishikawa T, Ohnishi H, Seishima M,

Kakumu S, Moriwaki H. Lack of tumor necrosis factor alpha induces impaired proliferation

of hepatitis B virus-specific cytotoxic T lymphocytes. J ViroI2oo3;77:2469-2476.

Kiba T, Saito S, Numata K, Sekihara H. Fas (APO-I1CD95) mRNA is down-regulated in liver

regeneration after hepatectomy in rats. J GastroenteroI2oo0;35:34-38.

Kim H, Lee H, Yun Y. X gene product of HBV induces apoptosis in liver cells. The Journal

of Biochemistry 1998;273:381-385.

Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD.

Association ofTNF- {alpha} promoter polymorphisms with the clearance of hepatitis B virus

infection. Hum Mol Genet 2003; 12:2541-2546.

103

References

Kimura K, Ando K, Ohnishi H, Ishikawa T, Kakumu S, Takemura M, Muto Y, Moriwaki H.

Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly

administered concanavalin A. Int Immunol 1999; II: 1491-1500.

Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen­

presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol

2002; 169:5188-5195.

Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and

susceptibility to infectious disease. Proc Assoc Am Physicians 1999; III :290-298.

Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the

development of hepatitis. Nat Med 1997;3:409-413.

Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced

liver injury and fibrosis in interleukin-6-deficient mice. Hepatol 2000;31: 149-159.

Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6

protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic

proteins FLIP, Bcl-2, and Bel-xl. J BioI Chern 2001;276:26605-26613.

Koziel MJ. The immunopathogenesis of hepatitis B virus infection. Therap. Viral Hepat

1998;3:13-24.

Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination:a

review. Commun Dis Public Health 2003;6:106-112.

Kuma S, Inaba M, Ogata H, Inaba K, Okumura T, Saito K, Yamamoto M, Ikehara S. Effect of

human recombinant interleukin-6 on the proliferation of mouse hepatocytes in the primary

culture. Immunobiology 1990; 180:235-242.

Kunkel LM, Smith KD, Boyer SH, Bargaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones

HW Jr, Rary 1M. Analysis of human Y-chromosome-specific reiterated DNA in chromosome

variants. PNAS USA 1977;74:1245-1249.

104

References

Kiisters S, Tieges G, Alexopoulou L, Pasparakis M, Douni E, Kiinstle, BluethmannH, Wendel

A, Pfizenmaier K, Kollias G, Grell M. In vivo evidence for a functional role of both tumor

necrosis factor receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol

1997;27:2870-2875.

Lanier LL. NK cell receptors. Annu Rev Immunoll998;16:359-393.

Lanvin 0, Guglielmi P, Fuentes V, Gouilleux-Gruart V, Maziere C, Bissac E, Regnier A,

Benlagha K, Gouilleux F, Lassoued K. TGF-betal modulates Fas (APO-lICD95)-mediated

apoptosis of human pre-B cell lines. Eur J ImmunoI2003; 33:1372-1381.

Lara-Pezzi E, Armesilla AL, Majano PL, Redondo JM, Lopez-Cabrera M. The hepatitis B

virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A­

sensitive pathway. EMBO J 1998 a;17:7066-7077.

Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, Garcia-Monzon C, Moreno-Otero R, Levrero

M, Lopez-Cabrera M. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha

gene expression in hepatocytes. Hepatoll998 b;28:1013-1021.

Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet

1993;342: 1335-1340.

Lau JYN, Xie X, Lai MMC, Wu PC. Apoptosis and viral hepatitis. Seminars in Liver

Diseases 1998:2:169-176.

Lee JC, Lee KM, Kim DW, Heo DS. Elevated TGF-betal secretion and down-modulation of

NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 2004; 172:7335-

7340.

Lee M, Choi Y, Shin E, Kang H, Kim Y, Jeong S, Seong J, Yu D, Cho H, Park J, Kim S.

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18):a potential

mechanism for liver injury caused by hepatitis B virus (HBV) infection. J Hepatol

2002;37:380.

105

References

Lee WM. Hepatitis B virus infection. N. Engl J Moo 1997;337:1733-1745.

Leu n, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-betal activation

after Fas ligand treatment of IGF binding protein-l-deficient mice. J Clin Invest

2003;111:129-139.

Lim TM, Chen CJ, Wu M.M, Yang CS, Chen JS, Liu CC, Kwang TY, Hsu ST, Lin SY, Hsu

LC. Hepatitis B virus markers in Chinese twins. Anticancer. Res 1989;9:737-741.

Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transfonning

growth factor beta 1. Cancer Res. 1992; 52:385-388.

Lisa V, Guidotti LG, Ishikawa T, Chisari FV. Posttranscriptional clearance of hepatitis B

virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. NatI. Acad. Sci. USA

1995;92: 12398-12402.

Liu W, Smith Of, Rechtzigel KJ, Thibodeau SN, James CD. Denaturing high perfonnance

liquid chromatography (DHPLC) used in the detection of gennline and somatic mutations.

Nucleic Acids Res 1998;26:1396-1400.

Loffreda S, Rai R, Yang SQ, Lin HZ, Diehl AM. Bile ducts and portal and central veins are

major producers of tumor necrosis factor alpha in regenerating rat liver. Gastroenterol

1997;112:2089-2098.

Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-l0

polymorphisms on interleukin-l0 expression and survival in critically ill patients. Crit Care

Med 2003;31 :34-38.

Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL, Hu QY, Li H. Association of -238G/A

polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of

hepatitis B virus infection in Chinese Han population. World J Gastroenterol 2004;10:1810-

1814.

106

References

Lu X, Weiss P, Block T.A phage with high affinity for hepatitis B surface antigen for the

detection of HBsAg.2004; 119:51-54.

Luo KX. Hepatitis B:Basic biology and clinical science. Second edition. Beijing, People's

Medical Publishing House 200 1 :56-70.

MacCallum F O. Homologous Serum Jaundice. Lancet 1947;2:691-692.

Mahoney FJ, Kane M. Hepatitis B vaccine. In:Plotkin SA, Orenstein WA, eds. Vaccines, 3rd

ed. Philadelphia, W.B. Saunders Company, 1999:158-182.

Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, Larrubia JR, Webster GJ,

McMichael AJ, Ferrari C, Williams R, Vergani D, Bertoletti A. Direct ex vivo analysis of

hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

Gastroenterology 1999; 117: 1386-1396.

Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R,

Alisa A, Williams R, Vergani D, Naoumov NY, Ferrari C, Bertoletti A. The role of virus­

specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus

infection. J Exp Med 2000;191:1269-1280.

Marcellin P and Benhamou JP. Treatment of chronic viral hepatitis. Baillieres Clin

Gastroenterol 1994;8:233-253.

Marinos G, Naoumov NV, Rossol S, Torre F, Wong PYN, Gallati H, Portmann B, Williams

R. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.

Gastroenterol 1995; 1 08: 1453-1463.

McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF­

alpha promoter region associated with susceptibility to cerebral malaria. Nature

1994;371 :508-510.

107

References

McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536

Alaska Natives chronically infected with hepatitis B virus. Annals of Internal Medicine

2001;135:759-768.

Merikangas KR. Genetics of migraine and other headache. Curr Opin Neurol 1996;9:202-205.

Metcalfe JC. A transforming growth factor betal signal peptide variant increases secretion in

Meyer D, Gong ZL, Suwandhi W, Pelt J van, Yap SH. Organ and species specificity of

hepatitis B virus (HBV) infection:a review of literature with a special reference to preferential

attachment ofHBV to human hepatocytes. J Viral Hepatitis 1997;4:145-153.

Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;2276:60-66.

Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajimf. K, Nakao K, Daikoku M, Yatsuhashi

H, Koga M, Yano M, Eguchi K. Influence of interleukin-l 0 gene promoter polymorphisms on

disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol

2002;97:208&-2092.

Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto

H, Kamada T. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J

Hepatol 1996;24:1-7.

Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea.

Hepatology. 2000;31: 1371-1373.

Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL,

Kanagawa 0, Chisari FV. Immunobiology and pathogenesis of hepatocellular injury in

hepatitis B virus transgenic mice. Science 1990;248:361-364.

Mosmann TR. Properties and functions of interleukin-l O. Adv Immunol 1994;56; 1-26.

Mota A, Fainboim R, Terg R, Fainboim L. Association of chronic active hepatitis and HLA­

B35 in patients with hepatitis B virus. Tissue Antigens 1987;30:238-240.

t08

References

Mouri H,Sakaguchi K, Sawayama T, Senoh T, Ohta T, Nishimura M, Fujiwara A, Terao M,

Shiratori Y, Tsuji T. Suppressive effects of transforming growth factor-beta 1 produced by

hepatocellular carcinoma cell lines on interferon-gamma production by peripheral blood

mononuclear cells. Acta Med Okayama 2002;56:309-315.

Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming

growth factor-betal concentrations in patients with chronic viral hepatitis. J Gastroenterol

Hepatol 1998;13:680-684.

Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H,

Yamada T, Okumura K, Nakano H. The Alteration of Fas Receptor and Ligand System in

Hepatocellular Carcinomas: How Do Hepatoma Cells Escape from the Host Immune

Surveillance In Vivo. Hepatol 1999;30:413-421.

Nagy P, Schaff Z, Lapis K. Immunohistochemical detection of transforming growth factor­

beta 1 in fibrotic liver diseases. Hepatol 1991; 14:269-273.

Napoli J, Bishop GA, McCaughan GW.lncreased intrahepatic messenger RNA expression of

interleukins 2,6, and 8 in human cirrhosis. GastroenteroI1994;107:789-798.

Oberhamme FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte­

Hermann R. Induction of Apoptosis in Cultured Hepatocytes and in Regressing Liver by

Transforming Growth Factor B1. Proc. Nat. Acad. of Sci. USA, 1992;89:5408-5412.

Ogaswara J, Watanabe-Fukunaga R, Adashi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh

N, Suda T, Nagata S. Lethal effects of the anti-Fas antibody in mice. Nature 1993;364:806-

809.

Ohno H, Kaneko S, Kobayashi K, Murakami S. Human hepatitis B virus enhancer 1 is

responsive to human interleukin-6. J Med Virol 1997;52:413-418.

Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y, Sekikawa K and Nishimura

T. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury

109

References

mediated by Thl cells specific to hepatitis B virus surface antigen. J Immunol2000 ;165:956-

961.

Okochi K, Murakami S. Observations on Australia Antigen in Japanese. Vox Sang

1968;15:374-385.

Olomolaiye 0, Wood NA, Bidwell JL. A novel NlaIII polymorphism in the human IL-6

promoter. Eur J Immunogenet 1998;25:267.

Ostapchuk P, Hearing P, Ganem A dramatic shift in the transmembrane topology of a viral

envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J 1994 ; 13: 1 048-

1057.

Ou JH, Laub 0, Rutter WJ. Hepatitis B virus gene functions:the precore region targets the

core antigen to cellular membranes and causes the secretion of the e antigen. PNAS USA

1986:83: 1578-1582.

Park BL, Lee HS, Kim YJ, Kim JY, Jung JH, Kim LH, Shin HD. Association between

interleukin 6 promoter variants and chronic hepatitis B progression. Exp Mol Med

2003;35:76-82.

Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. Host-virus interactions during

malaria infection in hepatitis B virus transgenic mice. J Exp Med 2000; 192:529-536.

Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. Cytokine-sensitive

replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol

2002;76:5646-5653.

Patel T, Steer CJ, Gores GJ. Apoptosis and the Iiver:A mechanism of disease, growth

regulation, and carcinogenesis. Hepatology 1999;30:811-815.

Peng DQ, Zhao SP, Nie S, Li J. Gene-interaction ofPPAR-y and APOE effects coronary heart

disease risk. IntematJ Cardio 2003;92:257-263.

110

References

Perneger TV. What's wrong with onferroni adjustments? BMJ 1998;316:1236-1238.

Poland GA, Jacobson RM. Prevention of Hepatitis B with the Hepatitis B Vaccine. N Eng J

Med 2004.351 :2832-2838.

Prange R Streeck RE. Novel transmembrane topology of the hepatitis B virus envelope

proteins. EMBO J 1995;14:247-256.

Prince AM. An Antigen Detected in the Blood During the Incubation Period of Serum

Hepatitis. Proc. Natl Acad Sci USA 1968;60:814-821.

Rehermann B, Fowler P, Sidney J. The cytotoxic T lymphocyte response to multiple hepatitis

B virus polymerase epitopes during, after acute viral hepatitis. J Exp Med 1995;181:1047-

1058.

Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades

after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T­

lymphocyte response. Nat Med 1996;2: 11 04-1108.

Reichner JS, Mulligan JA, Spisni R, Sotomayor EA, Albina JE, Bland KI. Effect of IL-6

overexpression on the metastatic potential of rat hepatocellular carcinoma cells Ann. Surg

OncoI1998;5:279-286.

Relton CL, Wilding CS, Pearce MS, Laming AJ, Jonas PA, Lynch SA, TaWIl EJ, Bum J.

Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK

population. J Med Genet 2004;41 :256-260.

Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T,

Korenaga K, Yamashita S, Konishi T, Okita K. Cytokine-dependent anti-viral role of CD4-

positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med

Virol 2003;71 :376-384.

Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge

between a CD4+ T-helper and a T-killer cell. Nature 1998;393:474-478.

I I I

References

Rivero M, Crespo J, Fabrega E, Casafont F, Mayorga M, Gomez-Fleitas M, Pons-Romero F.

Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral

Hepatology 2002;9:107-113.

Robinson, WS, Greenman, RL DNA Polymerase in the Core of the Human Hepatitis B Virus

Candidate. J ViroI1974;13:1231-1236.

Robinson WS. Hepatitis B virus and hepatitis D virus. In:Mandell GL, Bennett JE, Dolin R,

eds. Principles and Practice of Infectious Diseases, 4th ed. New York, Churchill Livingstone,

1995: 1406-1439.

Robson KJH, Lehmann DJ, Wimhurst VLC, Livesey KJ, Combrinck M, Menyweather­

Clarke AT, Warden DR, Smith AD. Synergy between the C2 allele of transferring and the

C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's

disease. J Med Genet 2004;41:261-265.

Romero LI, Tatro JB, Field JA, Reichlin S. Roles of IL-l and TNF-alpha in endotoxin­

induced activation of nitric oxide synthase in cultured rat brain cells. Am J Physiol

1996;270:R326-332

Roosenick MJ, Jameel S, Loukin SH, Siddiqui A. Expression of hepatitis B viral core regions

in mammalian cells. Mol. Cell. Bioi 1986;6:1391-1400.

Rouquet N, Allemand I, Molina T, Bennoun M, Briand P, Joulin V. Fas-dependent apoptosis

is impaired by S V 40-T antigen in transgenic liver. Oncogene 1995; 11 : 1061-1067.

Rouvier E, Luciani M F, Golstein P. Fas involvement on Ca2+-independent T cell-mediated

cytotoxicity. J Exp Med 1993;177:195-200.

Rudner LA, Lin JT, Park IK, Cates JM, Dyer DA, Franz DM, French MA, Duncan EM,

White HD, Gorham JD. Necroinflammatory liver disease in BALB/c background, TGF-beta

I-deficient mice requires CD4+ T cells. J ImmunoI2003;170:4785-4792.

112

References

Saba A, Bairwa NK, Ranjan A, Gupta V, Bamezai R. Two novel somatic mutations in the

human interleukin 6 promoter region in a patient with sporadic breast cancer. Eur J

Immunogenet 2003;30:397-400.

Saba A, Gupta V, Bairwa NK, Malhotra D, Bamezai R. Transforming growth factor-betal

genotype in sporadic breast cancer patients from India: status of enhancer, promoter, 5'­

untranslated-region and exon-l polymorphisms.Eur J Immunogenet 2004;31 :37-42.

Santos AR, Almeida AS, SuftYs PN, et al. Tumor necrosis factor promoter polymorphism

(TNF2) seems to protect against development of severe forms of leprosy in a pilot study in

Brazilian patients. Int J Lepr Other Mycobact Dis 2000;68:325-327.

Santos AR, SuftYs PN, Vanderborght PRo Moraes MO, Vierira LM, Cabello PH, Bakker AM,

Matos HJ, Huizinga TW, Ottenhoff TH, Sampaio EP, Sarno EN. Role of tumor necrosis

factor-alpha and interleukin-l0 promoter gene polymorphisms in leprosy. J Infect Dis

2002; 186: 1687-1691.

Sattler F, Robinson W. Hepatitis B viral DNA molecules have cohesive ends. J Virol

1979;32:226-233.

Schirmbeck R, Melber K, Kuhrober A, Janowicz ZA, Reimann J. Immunization with soluble

hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T

lymphocyte responses in vivo. J Immunol 1994;152:1110-1119.

Schramm C, Protschka M, Kohler HH, Podlech J, Reddehase MJ, Schirmacher P, Galle PRo

Lohse AW, Blessing Ms. Impairment ofTGF-beta signaling in T cells increases susceptibility

to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol

2oo3;284:G525-535.

Schulze-Bergkamen H, Untergasser A, Dax A, Vogel H, Buchler P, Klar E, Lehnert T, Friess

H, Buchler MW, Kirschfink M, Stremmel W, Krammer PH, Muller M, Protzer U. Primary

human hepatocytes-a valuable tool for investigation of apoptosis and hepatitis B virus

infection. Exp Mol PathoI2001;71:137-146.

113

References

Scola L, Crivello A, Marino V, Gioia V, Serauto A, Candore G, Colonna-Romano G, Caruso

C, Lio D. IL-I0 and TNF-alpha polymorph isms in a sample of sicilian patients affected by

tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev

2003;124:569-572.

Seeff LB, Wright EC, Zimmerman HJ, McCollum RW. A cooperative study of post­

transfusion hepatitis and responsible risk factors. Am J med Sci 1979;270:355-362.

Seeger C, William S. Mason. Hepatitis B Virus Biology. Microbiology and Molecular

Biology Reviews 2oo0;64:F 51-68.

Servoss JC, Friedman LS. Serologic and molecular diagnosis of hepatitis B virus. Clin Liver

Dis 2004;8:267-281.

Sheron N, Lau JYN, Daniels H, Goka J, Eddleston ALWF, Alexander GJM, Williams R.

Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection. J

HepatoI1991;12:241-245.

Shin EC, Shin JS, Park JH, Kim JJ, Kim H, Kim SJ. Expression of Fas-related genes in

human hepatocellular carcinomas. Cancer Lett 1998; 134: 155-162.

Shin EC, Shin JS, Park JH, Kim H, Kim SJ. Expression of fas ligand in human hepatoma cell

lines:role of hepatitis-B virus X (HBX) in induction of Fas ligand. Int J Cancer 1999;82:587-

591.

Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT,

Morgan GJ. Functional F AS promoter polymorphisms are associated with increased risk of

acute myeloid leukemia. Cancer Res 2003;63:4327-4330.

Sigal U, Crotty S, Andino R, Rock KL. Cytotoxic T-cell immunity to virus-infected non-

haematopoietic cells requires presentation of exogenous antigen. Nature 1999;398:77-80.

Sitia G, lsogawa M, Kakimi K, Wieland SF, Chisari FV, Guidotti LG. Depletion of

neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting

114

References

the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci

USA 2002;99 :13717-13722.

Song Ie H, Binh VQ, Duy DN, Juliger S, Bock TC, Luty AJ, Kremsner PG, Kun JF.

Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese

patients. Mutat Res 2003;522:119-125.

Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences

on premature death in adult adoptees. N. Engl. J. Med 1988;318:727-732.

Spielman RS, McGinnis RE, EwensWJ. Transmission test for linkage disequilibrium:the

insulin gene region and Insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet

1993;52;506-516.

Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor­

beta:biological function and chemical structure. Science 1986;233:532-534.

Storms SD aild Rutishauser U. A role for polysialic acid in nueral cell adhesion molecule

heterophilic binding to proteoglycans. I BioI Chem 1998;273:27124-27129.

Strand S, Hofinann WI, Hug H, Muller M, Otto G, Strand D. Lymphocyte apoptosis induced

by CD95 (APO-l/Fas) ligand expressing tumor cells - a mechanism of immune evasion? Nat.

Med 1996;2:1361-1367.

Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut

2000;47:309-312.

Suda T, Takahasi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas

ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.

Su F, Schneider R I: HBx sensitizes cell to apoptotic killing by TNF -0.. Proc Natl. Acad. Sci.

USA 1997;94:8744-8749.

115

References

Sullivan DE, Ferris M, Pociask D, Brody AR. TNF-{alpha} Induces TGF-{beta} 1 Expression

in Lung Fibroblasts Through the ERK Pathway. Am J Respir Cell Mol Bioi 2005

Tacket CO, Roy MJ, Widera G, Swain WF, Broome S, Edelman R. Phase I safety and

immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by

a gene delivery device. Vaccine 1999; 17 :2826-2829.

Taira K, Hiroyasu S, Shiraishi M, Muto Y, Koji T. Role of the Fas system in liver

regeneration after a partial hepatectomy in rats. Eur Surg Res 2001;33:334-341.

Takehara T, Hayashi N, Mita E, Kanto T, Tatsmni T, Sasaki Y, Kasahara A, Hori M. Delayed

Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of

TNF alpha. Hepatology 1998;27:1643-1651.

Takiya S, Tagaya T, Takahashi K, Kawashima H, Kamiya M, Fukuzawa Y, Kobayashi S,

Fukatsu A, Katoh K, Kakumu S. Role of transforming growth factor beta I on hepatic

regeneration and apoptosis in liver diseases. J Clin Pathol 1995;48: 1093-1097.

Talmud P, Lins L, Brasseur R. Prediction of signal peptide functional properties:a study of the

orientation and angle of insertion of yeast invertase mutants and human apolipoprotein B

signal peptide variants. Protein Enginnering 1996; 9:317-321.

Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ,

Wakefield LM.Transforming growth factor-betal is a new form of tumor suppressor with true

haploid insufficiency. Nat Med 1998;4:802-807.

Taub R. Hepatoprotection via the IL-6/Stat3 pathway. J C1in. Invest 2003;112:978-980.

Tay C, Welsh R. Distinct organ dependent mechanisms for the control of murine

cytomegalovirus infection by natural killer cells. J Virol 1997;71 :267-275.

Terradillos 0, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA.

p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.

Oncogene 1998; 17:2115-2123.

116

References

Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on

Interleukin 6 transcription regulation. J Bioi Chern 2000;275:18138-18144.

Thimme R, Wieland S, Steigeer C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+)

T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus

infection. J ViroI2003;77:68-76.

Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski JA,

Thomas DL. Class II of HLA alleles and hepatitis B Virus persistence African Americans. J

Infect Dis 1999; 179: 1 004-1 006.

Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome.

Hepatology 2000;31 :819-827.

Thomas HC, Foster GR, Sumiya M, Mcintosh D, Jack DL, Turner MW, Summerfield JA.

Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral

infection. Lancet 1996;348: 1417-1419.

Thomson RK, Arthur MJP. Mechanisms of liver cell damage and repair. Europ j

Gastroenterol Hepatology 1999; 11 :949-955.

Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res 2001;52:113-116.

Todd JA, FarraH M. Panning for gold:genome-wide scanning for linkage in type I diabetes.

Hum Mol Genet 1996;5:1443-1448.

Tsai SL, Sheen IS, Chien RN, Chu CM, Huang HC, Chuang YL, Lee TH, Liao SK, Lin CL,

Kuo GC, Liaw YF. Activation of Th 1 immunity is a common immune mechanism for the

successful treatment of hepatitis B and C:tetramer assay and therapeutic implications. J

Biomed Sci 2003;10:120-135.

van Deventer S1. Cytokine and cytokine receptor polymorph isms m infectious disease.

Intensive Care Med 2000;26 (Suppl I ):S98-1 02.

117

References

Wang FS. Current status and prospects of studies on human genetic alleles associated with

hepatitis B virus infection. World J GastroenteroI2003;9:641-644.

Wang JY, Wang XL, Liu P. Detection of serum TNF-alpha, IFN-beta,IL-6 and IL-8 10

patients with hepatitis B. World J Gastroenterol 1999;5:38-40.

Wang WH, Gregori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen­

activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein

mediates apoptosis via induction of FaslFasL and tumor necrosis factor (TNF) receptor

IffNF-alpha expression. Mol Cell Bioi 2004;24:10352-10365.

Wang XW, Forrester K, Yeh H. Hepatitis B virus X protein inhibits p53 sequence-specific

DNA binding, transcriptional activity and association with transcription factor ERCC3. Proc

Natl Acad Sci USA 1994;91:2230-2234.

Wang XW, Gibson MK., Venneulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers

JH, Harris CC. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.Cancer

Res 1995;55:6012-6016.

Watanabe-Fukunage R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins N A, Nagata

S. The eDNA structure, expression, chromosomal assignment of the mouse Fas antigen. J

Immuno 1992;148:1274-1279.

Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amiot PL,

Williams R, Vergani D, Dusheiko GM, Bertoletti A. Incubation phase of acute hepatitis B in

man:dynamic of cellular immune mechanisms. Hepatology 2000;32: 1117 -1124.

Westendorp RG, Langennans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on

cytokine production in meningococcal disease. Lancet 1997; 349:1912-1913.

Wilson AG, de Vries N, Pociot F, di Giovine FS, van de Putte LB, Duff GW. An allelic

polymorphism within the tumour necrosis alpha promoter region is strongly associated with

HLAI, 88, DR3 alleles. J. Immunol 1993;177:557.

118

References

Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human

tumour necrosis factor alpha promoter on transcriptional activation. PNAS 1997;94:3195-

3199.

World Health Organization 1973. Viral Hepatitis Repository of WHO Scientific Group. WHO

Technical Report Series 512. Geneva:WHO.

Wuestefeld T, Klein C, Steetz KL, Betz U, Lauber J, Buer J, Manns MP, Mueller W,

Trautwein C. IL6/GP130-dependent pathways are protective during liver regeneration. J BioI

Chern 2003;278:11281-11288.

Xing T, Zhang L, Lu Q, Hou J, Feng X, Luo K. ThllTh2 type cytokines in hepatitis B patients

treated with interferon-alpha. Chin Med J (Engl) 2001;114:921-924.

Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis

factor:deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc

Natl Acad Sci USA 1997;94:1441-1446.

Yamagishi, Y, Hashimoto, Y, Niikura, T. & Nishimoto, I. (2003) Identification of essential

amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults.

Peptides;24:585.

Yarbough PO. Hepatitis E virus. Intervirology 1999;42:179-184.

Via Y-S, Parka SG, Byeona SM, Kwonb Y-G, Junga G. Hepatitis B virus X protein induces

TNF-alpha expression via down-regulation of selenoprotein P in human hepatoma cell line,

HepG2. Biochim Biophys Acta 2003; 1638:249-256.

Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene

mutations are associated with progression of liver disease in chronic hepatitis B infection.

Hepatology 1999;29: 1248-1251.

119

References

Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery:a single nuclear localization signal

peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 1999;96:91-

96.

Zavaglia C, Bortolon C, Ferrioli G, Rho A, Mondazzi L, Bottelli R, Ghessi A, Gelosa F,

lamoni G, Ideo G. HLA typing in chronic type B, D and C hepatitis. J Hepatol 1996;24:658-

665.

Zhang W, Vue B, Wang GQ, Lu SL. Serum and ascites levels of macrophage migration

inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus·hepatitis B and hepatitis

cirrhosis.Hepatobiliary Pancreat Dis Int 2002; 1 :577-580.

Zimmers TA, McKillop rn, Pierce RH, Yoo JY, Koniaris LG. Massive liver growth in mice

induced by systemic interleukin 6 administration. Hepatology 2003;38:326-334.

Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine

residue of the polymerase. J Viro11994 a;68:6-13.

Zoulim F, Saputelli J, SeegerC. Woodchuck hepatitis virus X protein is required for viral

infection in vivo. J Virol 1994 b;68:2026-2030.

120